Since a large number of cancers, and especially blood cancers, exhibit loss of cellular identity [37], knocking the SMC1A-R586W mutation into mESCs allows for investigation of potential aberrant cellular identity and the molecular mechanisms that underlie it. Here, SMC1A is linked to hematopoietic and lymphoid system neoplasm.